HNN3.0
Register
Register
Register

Arcturus Therapeutics

Company (Industry)

arcturusrx.com/San Diego, United States

About

At Arcturus Therapeutics, we are dedicated to pioneering mRNA medicines that have the potential to transform the treatment landscape for various diseases. Our innovative platform focuses on the development of novel RNA-based therapeutics, including vaccines and therapies for infectious diseases and genetic disorders. We achieved a major milestone with KOSTAIVE® (ARCT‑154), the world’s first self‑amplifying mRNA (sa‑mRNA) COVID‑19 vaccine to receive regulatory approval, including marketing authorization from the European Commission, with commercialization in Japan. Arcturus develops both conventional mRNA and self‑amplifying mRNA therapeutics, enabled by its proprietary STARR™ sa‑mRNA platform and LUNAR® lipid delivery technology, designed to support durable protein expression and efficient intracellular delivery. We strive to revolutionize healthcare and improve patient outcomes through cutting-edge technology and scientific excellence.

Representatives

Director of Program Management

Arcturus Therapeutics